AlayaCare Announces New $3.2M Project to Drive AI Solutions in Canadian Home Care
MONTREAL, QC / ACCESSWIRE / February 29, 2024 / AlayaCare, a leading home care technology platform, announced today a new...
Day: February 29, 2024
Cosmos Health Successfully Completes Acquisition of Pharmatrade’s Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million
CHICAGO, IL / ACCESSWIRE / February 29, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
The First-Ever Transplantation with a Donor Heart Transported Across the Atlantic Ocean – Made Possible by the use of XVIVO’s Heart Technology
GOTHENBURG, SE / ACCESSWIRE / February 29, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The Lancet reports that for the first...
Liviniti Partners with Mindera Health to Improve Psoriasis Patient Care and Reduce Specialty Pharmacy Spend
Innovative collaboration will improve patient outcomes and cost savings through reduced trial-and-error management of biologic therapiesNatchitoches, Louisiana--(Newsfile Corp. - February...
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
Aldrich’s proven commercial, operational and leadership expertise helps position EndoSound for EVS launch and sustainable growthPORTLAND, Ore.--(BUSINESS WIRE)--EndoSound™ Inc., a...
Red Light Holland Reports Third Quarter 2024 Results and Reminder to Shareholders of the Live Q&A Today at 4pm ET
Cash balance of $15.4 million as at December 31, 2023Revenue of $1.3 million (vs 2022: $1.2 million, an increase of...
Stone Diagnostics Announces Strategic Partnership With Altus Ace (ACE)
Stone Diagnostics' State-of-the-Art Preventive Diagnostic Testing Platforms Empower ACE Providers to Optimize Patient Outcomes With Preventative Diagnostic Testing SolutionsSANTA ROSA...
Fremedica Partners with UBC Men’s Hockey Team to Launch an Innovative Sports Performance Enhancement & Recovery Program
VANCOUVER, BC / ACCESSWIRE / February 29, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is thrilled...
Gilead Sciences: National Black HIV/AIDS Awareness Day
NORTHAMPTON, MA / ACCESSWIRE / February 29, 2024 / This year's theme for National Black HIV/AIDS Awareness Day is "Engage,...
Biotricity Receives Health Canada Clearance for Biotres
Well Positioned to Enter US $1.56 Billion Canadian Cardiology Devices MarketREDWOOD CITY, CA / ACCESSWIRE / February 29, 2024 /...
Inspire Veterinary Partners Announces New Employee Benefit Program With BetterHelp to Support the Wellbeing of Staff
VIRGINIA BEACH, VA / ACCESSWIRE / February 29, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an...
Avant Brands Reports Record-Breaking Results in Fiscal Year 2023
KELOWNA, BC / ACCESSWIRE / February 29, 2024 / Avant Brands Inc (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer...
Moderna to Host Fifth Annual Investor Event For Vaccines and Business Updates on March 27, 2024
CAMBRIDGE, MA / ACCESSWIRE / February 29, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host its fifth...
AIM ImmunoTech Outlines Recent Progress Across Clinical Development Pipeline and Provides Business Update
Company continues progress across Ampligen® clinical development programs Growing body of promising data demonstrates Ampligen’s potential to address multiple high-value...
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in...
Yield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Tests
-Herbicide tolerance is critical to planting the Camelina crop on large acreage for the biofuel and omega-3 oil marketsWOBURN, Mass.,...
SpringWorks Therapeutics Announces European Medicines Agency Validation for Marketing Authorization Application of Nirogacestat for the Treatment of Adults with Desmoid Tumors
Application based on Phase 3 DeFi trial in which nirogacestat significantly improved progression-free survival and objective response rate compared to...
Independent Lab Confirms Immunogenicity and Protection with IMUNON’s IMNN-101 in a Live Virus Challenge Against SARS-CoV-2 Variant XBB.1.5
Murine Study by the Wistar Institute Builds Upon Favorable Results Previously Reported by IMUNON With its Prototype PlaCCine Vaccine Modality...
CytoDyn Announces FDA Has Lifted Clinical Hold
Webcast to Provide Company Update on March 5, 2024 VANCOUVER, Washington, Feb. 29, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB:...
Intercept Announces FDA Acceptance of Supplemental New Drug Application for Ocaliva® (obeticholic acid) for the Treatment of PBC
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing...